Curis Inc
Symbol: CRIS (NASDAQ)
1.63
0.00 0.000
Company Description:
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Key Stats
- Today's Open: $1.66
- Today's High: $1.665
- Today's Low: $1.6
- Today's Volume: 121.66K
- Yesterday Close: $1.63
- Yesterday High: $1.63
- Yesterday Low: $1.48
- Yesterday Volume: 66.26K
- Last Min Volume: 700
- Last Min High: $1.63
- Last Min Low: $1.617
- Last Min VWAP: $1.617
Company Profile
- Name: Curis Inc
- Website: https://www.curis.com
- Listed Date: 2000-08-01
- Location: LEXINGTON, MA
- Market Status: Active
- CIK Number: 0001108205
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $20.37M
- Round Lot: 100
- Outstanding Shares: 12.50M
- Asset Type: CS
RECENT FILINGS FOR CRIS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-24 | 8-K | View |
| 2025-08-22 | 8-K | View |
| 2025-08-18 | EFFECT | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | CORRESP | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-13 | UPLOAD | View |
| 2025-08-11 | S-1 | View |
| 2025-08-08 | 8-K | View |
| 2025-08-08 | 424B5 | View |
| 2025-08-05 | 10-Q | View |
| 2025-08-05 | 8-K | View |
| 2025-07-02 | 424B5 | View |
| 2025-07-02 | FWP | View |
| 2025-07-02 | 8-K | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
Latest News on CRIS